50 - pre-FDA decision - but the market Tuesday and Wednesday seemed to agree that IGXT has a bright near-term future with the stock closing each day at higher levels as compared to those just preceding the run up to the FDA decision. …
SAINT LAURENT, Quebec, May 15, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) …
This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from Robert Marcin ... IntelGenx Technologies Corp. (OTC Pink: IGXT) - The small pharmaceutical company is developing a …
A year ago, they were trading at 74 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IGXT …
Yahoo!1mon
IGXT) announced today that the Company's board of directors granted options to acquire a total of 359,818 common shares under the 2016 Stock Option Plan. Of the total stock options granted, 179,908 were granted to the Horst G. Zerbe, …
Since we adjusted down our 2016 EPS estimate to zero, we're using our 2017 EPS estimate to value IGXT on a P/E basis; the stock trades at 6.0x our FY:17 EPS estimate of $0.09. On a price to revenue basis, the stock is trading at 7.8x …
A year ago, they were trading at 74 cents. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IGXT …